Nov 15, 2023 / 01:00PM GMT
Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Okay. Welcome, everybody, to day 2 of the 2023 Stifel Healthcare Conference. This is a life sciences and diagnostics track. We're happy to kick things off this morning with Repligen. I have CEO, Tony Hunt; and CFO, Jason Garland, with me here. Guys, thanks very much for spending some time this morning.
Anthony J. Hunt - Repligen Corporation - CEO & Director
Good morning.
Jason K. Garland - Repligen Corporation - CFO
Yes. Good to hear.
Questions and Answers:
Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior AnalystJason, maybe since this is our first time getting to chat with you in a public forum, I'll just start with you, if I can. You arrived at the company a couple of months ago. What at a high level would you say you've been spending most of your time focusing on?
Jason K.